BOA™ Biomedical’s GARNET™ therapeutic product begins First in Human clinical trial
BOA Biomedical’s GARNET™ therapeutic product begins FIH clinical trial
Defense Department Plans Study of COVID-19 Blood-Purification Treatment
The study, expected to begin later this year, will take place at Walter Reed National Military Medical Center and at nonmilitary hospitals.
BOA Biomedical seeks to address antibiotic resistance and sepsis
Harvard’s Wyss Institute and VC firm Miraki Innovation have created a joint venture BOA Biomedical, which is developing a device that could diagnose and treat infectious diseases.
Mass. Biomedical Company Works on Rapid Coronavirus Test
A Cambridge biomedical is developing a rapid coronavirus test that it hopes to have ready in a few months.